Liprotamase, a Non-porcine Enzyme Therapy, Restores Growth, and Normalizes Lipid Absorption in Pigs with Exocrine Pancreatic Insufficiency (EPI)

被引：1
作者：
Grujic, Danica [1 ]
Piedra, Jose [2 ]
Prykhodko, Olena [3 ]
Szymanczyk, Sylwia [2 ]
Pierzynowski, Stefan [2 ]
机构：
[1] R&D Alnara Pharmaceut, Cambridge, MA USA
[2] SGPLus, Malmo, Sweden
[3] Lund Univ, Dept Biol, Lund, Sweden
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷
关键词：
D O I：
10.14309/00000434-201010001-00136
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
136
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 21 条
  • [1] A NEW FORMULATION OF LIPROTAMASE RESTORES GROWTH & NORMALIZES LIPID ABSORPTION IN PIGS WITH EXOCRINE PANCREATIC INSUFFICIENCY (EPI)
    Grujic, D.
    Harrison, A.
    Piedra, J.
    Szymanczyk, S.
    Szwiec, K.
    Bala, T.
    Pierzynowski, S.
    PEDIATRIC PULMONOLOGY, 2010, : 416 - 416
  • [2] Liprotamase, a Microbial Enzyme Therapy, Reveresed Impaired Growth in a Model of Cystic Fibrosis: Pigs With Total Exocrine Pancreatic Insufficiency (EPI Pigs)
    Grujic, Danica
    Piedra, Jose L. Valverde
    Szymanczyk, Sylwia
    Pierzynowski, Stefan
    GASTROENTEROLOGY, 2010, 138 (05) : S149 - S149
  • [3] EFFECTS OF GASTRIC ACID SUPPRESSANTS ON RESPONSE TO LIPROTAMASE, A NON-PORCINE PANCREATIC ENZYME REPLACEMENT THERAPY IN PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CYSTIC FIBROSIS
    Wilschanski, M.
    Konstan, M.
    Wagener, J.
    Laki, I
    Boas, S.
    Sands, D.
    Olsen, C.
    Martin, R. S.
    Pennington, J.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S292 - S292
  • [4] COMPARISON OF BIOLOGICALLY-MANUFACTURED LIPROTAMASE, A NON-PORCINE PANCREATIC ENZYME REPLACEMENT THERAPY, TO PORCINE EXTRACTED PANCRELIPASE ON FAT AND PROTEIN ABSORPTION IN SUBJECTS WITH EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CYSTIC FIBROSIS
    Konstan, M.
    Wagener, J.
    Wilschanski, M.
    Laki, I
    Boas, S.
    Sands, D.
    Gangal, M.
    Martin, R. S.
    Pennington, J.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S290 - S290
  • [5] Analysis of Real World Patient Experience With Pancreatic Enzyme Replacement Therapy (PERT) in the Treatment of Exocrine Pancreatic Insufficiency (EPI)
    Barkin, Jodie A.
    Harb, Diala M.
    Kort, Jens M.
    Barkin, Jamie S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S19 - S20
  • [6] ECONOMIC IMPACT OF TREATMENT ADHERENCE IN EXOCRINE PANCREATIC INSUFFICIENCY (EPI) PATIENTS TREATED WITH PANCREATIC ENZYME REPLACEMENT THERAPY (PERT)
    Khandelwal, N.
    Wang, S.
    Johns, B.
    Vora, J.
    Castelli-Haley, J.
    Singh, V. K.
    VALUE IN HEALTH, 2018, 21 : S85 - S86
  • [7] Responses of Ileal and Fecal Microbiota to Withdrawal of Pancreatic Enzyme Replacement Therapy in a Porcine Model of Exocrine Pancreatic Insufficiency
    Hankel, Julia
    Moesseler, Anne
    Hartung, Clara Berenike
    Rath, Silke
    Schulten, Lisa
    Visscher, Christian
    Kamphues, Josef
    Vital, Marius
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [8] PHASE 3 COMPARISON OF HIGHER-DOSE LIPROTAMASE, A NONPORCINE PANCREATIC ENZYME REPLACEMENT THERAPY, TO PANCRELIPASE ON FAT AND PROTEIN ABSORPTION IN SUBJECTS WITH EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CYSTIC FIBROSIS
    Konstan, M.
    Wagener, J.
    Wilschanski, M.
    Gangal, M.
    Martin, R. S.
    Pennington, J.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 230 - 230
  • [9] Analysis of Real-World Patient Experience With Pancreatic Enzyme Replacement Therapy (PERT) in the Treatment of Exocrine Pancreatic Insufficiency (EPI)
    Barkin, J. A.
    Harb, D.
    Kort, J.
    Barkin, J. S.
    PANCREAS, 2021, 50 (07) : 1046 - 1047
  • [10] Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency
    Ritz, Sabrina
    Hahn, Daniela
    Wami, Haleluya T.
    Tegelkamp, Karin
    Dobrindt, Ulrich
    Schnekenburger, Juergen
    MICROBIAL CELL FACTORIES, 2020, 19 (01)
123